Researchers are exploring delivering super-specific AAVs through the brain's natural waste disposal system, which can carry ...
The anti-amyloid drug is designed for a limited course, where patients can stop treatment once they reach a level of ...
The focus on treating people who have no cognitive impairment raises questions about how to implement testing for those at ...
The trial will include patients with relapsed or refractory B-cell malignancies, including patients who have received prior CAR T-cell therapies.
After a promising Phase I read out on mKRAS-VAX in patients with hereditary cancer predisposition and pancreatic lesions, ...
In an investigator-initiated trial, researchers will evaluate TPST-4003 in autoimmune disorders like myasthenia gravis and multiple sclerosis.
Primary care docs in Sweden diagnosed Alzheimer's with the same accuracy as dementia specialists when they had access to beta ...
Telix Pharmaceuticals has opened a new radiopharmaceutical manufacturing and treatment facility in Melbourne, Australia, the company announced Thursday. Telix said the integrated facility in Melbourne ...
The approval is based on clinical trial data on intravenous Leqembi and data suggesting subcutaneous formulation leads to similar results.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results